Literature DB >> 3800353

In vitro susceptibility of Acinetobacter species to various antimicrobial agents.

K V Rolston, G P Bodey.   

Abstract

The in vitro activity of 18 antimicrobial agents against 40 clinical isolates each of Acinetobacter calcoaceticus subsp. anitratum and Acinetobacter lwoffi was studied. Most of the newer 4-quinolone derivatives were extremely active against these organisms. Newer beta-lactam agents, such as cefpirome, BMY 28142, and BRL 36650, were also extremely active, inhibiting all strains at clinically achievable levels. Most agents were two- to fourfold more active against A. lwoffi.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3800353      PMCID： PMC176529          DOI： 10.1128/AAC.30.5.769

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.

Authors:  I Garcia; V Fainstein; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

2.  Acinetobacter calcoaceticus septicemia in patients with cancer.

Authors:  K Rolston; Z Guan; G P Bodey; L Elting
Journal:  South Med J       Date:  1985-06       Impact factor: 0.954

3.  In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin.

Authors:  M J Basker; R A Edmondson; S J Knott; R J Ponsford; B Slocombe; S J White
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

4.  The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.

Authors:  A King; K Shannon; I Phillips
Journal:  J Antimicrob Chemother       Date:  1985-05       Impact factor: 5.790

5.  Antibiotics in patients with neutropenia.

Authors:  G P Bodey
Journal:  Arch Intern Med       Date:  1984-09

6.  In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents.

Authors:  W Mandell; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

7.  In vitro activity of BRL 36650, a new semisynthetic penicillin.

Authors:  J F Hoy; K V Rolston; D H Ho; M Alvarez; P Thirolf; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

8.  In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.

Authors:  G M Eliopoulos; A E Moellering; E Reiszner; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191
  8 in total
  10 in total

1.  Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6).

Authors:  W H Traub; M Spohr
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Cross resistance to ciprofloxacin and other antimicrobial agents among clinical isolates of Acinetobacter calcoaceticus biovar anitratus.

Authors:  I Shalit; M Dan; R Gutman; A Gorea; S A Berger
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

3.  Community-acquired bacteremic Acinetobacter calcoaceticus var. anitratus pneumonia.

Authors:  H Westh; J Terp
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

4.  Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.

Authors:  S Bajaksouzian; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.

Authors:  M A Visalli; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

6.  Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.

Authors:  M A Visalli; M R Jacobs; T D Moore; F A Renzi; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

7.  Antimicrobial susceptibility of Acinetobacter species.

Authors:  H Seifert; R Baginski; A Schulze; G Pulverer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.

Authors:  S K Spangler; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 9.  Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  L B Barradell; H M Bryson
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

Review 10.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.